JENBURPH1,037.80

Jenburkt Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Non-current Assets
+ Capital Work-in-Progress1.240.346.1
+ Other Intangibles0.40.20.2
+ Non-current Investments16.820.627.0
+ Long-term Loans0.00.00.0
+ Other Non-current Financial Assets0.759.934.7
+ Other Non-current Assets25.52.81.3
Current Assets
+ Inventories8.68.913.6
+ Trade Receivables19.520.724.4
+ Cash & Cash Equivalents4.17.45.6
+ Other Bank Balances75.117.347.5
+ Short-term Loans0.10.10.1
+ Other Current Financial Assets0.80.40.4
+ Other Current Assets1.41.73.4
Total Assets165.1196.2226.0
Equity
+ Equity Share Capital4.44.44.4
+ Other Equity / Reserves140.5167.4192.6
Liabilities
+ Other Non-current Financial Liab3.03.03.0
+ Deferred Tax Liabilities0.81.11.0
+ Borrowings — Current0.02.00.0
+ Trade Payables6.38.28.1
+ Other Current Financial Liab5.34.75.4
+ Provisions — Current0.91.66.6
+ Current Tax Liabilities1.60.31.1
+ Other Current Liabilities2.21.71.3
Total Equity & Liabilities165.1196.2226.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.